Pharmaceutical Product Development, (PPD) LLC
PPD, a Thermo Fisher Scientific company, is a global provider of clinical research solutions, including drug development, clinical trial management, laboratory services, and innovative technologies. With over three decades of experience and a vast network of sites worldwide, PPD is committed to accelerating drug development, improving trial efficiency, and delivering high-quality data to support regulatory success and patient access. The company emphasizes therapeutic expertise across multiple areas, adaptive trial designs, digital and decentralized solutions, and strategic partnerships to help clients bring treatments to market faster and more effectively.
Industries
Nr. of Employees
Very Large (1000+)
Pharmaceutical Product Development, (PPD) LLC
Products
GMP Laboratory Services
Provides analytical services for small molecules and biologics, including testing for APIs, drug products, and medical devices across all phases of drug development.
Preclarus Lab Solutions
Offers a suite of tools for data integration and management to enhance clinical trial performance and regulatory success.
Regulatory Affairs Solutions
Provides end-to-end regulatory services to navigate global regulatory environments and accelerate product approval.
Decentralized Clinical Trials (DCT)
Facilitates clinical trials using telemedicine and remote monitoring to improve recruitment and retention while ensuring data quality.
Accelerated Enrollment Solutions (AES)
Offers a network of global sites and patient data to streamline clinical trial recruitment and reduce timelines.
Integrated Clinical Development Consulting
Offers strategic consulting services across clinical development, regulatory strategy, and trial design to optimize drug development.
GMP Laboratory Services
Provides analytical services for small molecules and biologics, including testing for APIs, drug products, and medical devices across all phases of drug development.
Preclarus Lab Solutions
Offers a suite of tools for data integration and management to enhance clinical trial performance and regulatory success.
Regulatory Affairs Solutions
Provides end-to-end regulatory services to navigate global regulatory environments and accelerate product approval.
Decentralized Clinical Trials (DCT)
Facilitates clinical trials using telemedicine and remote monitoring to improve recruitment and retention while ensuring data quality.
Accelerated Enrollment Solutions (AES)
Offers a network of global sites and patient data to streamline clinical trial recruitment and reduce timelines.
Integrated Clinical Development Consulting
Offers strategic consulting services across clinical development, regulatory strategy, and trial design to optimize drug development.
Services
Comprehensive clinical development services spanning protocol design, site management, monitoring, biostatistics, pharmacovigilance and regulatory support across Phase I–IV.
Consultative services for early-phase programs including adaptive protocol development, statistical planning and access to early-phase operational capabilities.
Deployment of decentralized and hybrid trial elements including remote assessments, telemedicine visits, wearable data capture and patient-facing digital tools.
Targeted recruitment campaigns, community- and digital-based outreach, site feasibility assessments and real-time monitoring to accelerate enrollment and diversify trial populations.
Laboratory testing services including bioanalytical methods, biomarker assay development, central lab testing and vaccine-specific assays to support clinical programs.
Connected clinical supply chain and manufacturing services including CMC consulting, scale-up support, packaging/labeling and supply logistics to streamline development-to-supply handoffs.
Comprehensive clinical development services spanning protocol design, site management, monitoring, biostatistics, pharmacovigilance and regulatory support across Phase I–IV.
Consultative services for early-phase programs including adaptive protocol development, statistical planning and access to early-phase operational capabilities.
Deployment of decentralized and hybrid trial elements including remote assessments, telemedicine visits, wearable data capture and patient-facing digital tools.
Targeted recruitment campaigns, community- and digital-based outreach, site feasibility assessments and real-time monitoring to accelerate enrollment and diversify trial populations.
Laboratory testing services including bioanalytical methods, biomarker assay development, central lab testing and vaccine-specific assays to support clinical programs.
Connected clinical supply chain and manufacturing services including CMC consulting, scale-up support, packaging/labeling and supply logistics to streamline development-to-supply handoffs.
Expertise Areas
- Clinical trial management (Phase I–IV)
- Early-phase and adaptive trial design
- Decentralized and hybrid clinical trials
- Clinical data management and integration
Key Technologies
- Polymerase chain reaction (PCR)
- Electronic data capture (EDC) and eSource
- ePRO / eCOA platforms
- AI / machine learning for trial analytics
News & Updates
PPD was recognized as the Best CRO at the 18th annual Vaccine Industry Excellence (ViE) Awards, highlighting its success in vaccine development support.
Insights into strategies for managing high demand in medical information contact centers to improve efficiency and stakeholder engagement.
PPD’s Accelerator™ Drug Development solutions help clients get treatments to patients faster through integrated CRO and CDMO services.
Experts share insights on technological advancements, regulatory changes, and industry priorities shaping the future of biopharma and biotech.
An analysis of how increasing trial complexity drives up costs and strategies to mitigate these challenges.
Survey results highlighting trends, challenges, and opportunities in clinical development from industry leaders.
PPD was recognized as the Best CRO at the 18th annual Vaccine Industry Excellence (ViE) Awards, highlighting its success in vaccine development support.
Insights into strategies for managing high demand in medical information contact centers to improve efficiency and stakeholder engagement.
PPD’s Accelerator™ Drug Development solutions help clients get treatments to patients faster through integrated CRO and CDMO services.
Experts share insights on technological advancements, regulatory changes, and industry priorities shaping the future of biopharma and biotech.
An analysis of how increasing trial complexity drives up costs and strategies to mitigate these challenges.
Survey results highlighting trends, challenges, and opportunities in clinical development from industry leaders.